Payment from Gen-Probe Drives Sharp Q2 Revenue Increase for DiagnoCure | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics company DiagnoCure's fiscal second-quarter revenues more than tripled, it reported after the close of the market on Wednesday, driven in part by a milestone payment from Gen-Probe.

For the three months ended April 30, Quebec City-based DiagnoCure recorded C$1.1 million (US$1.1 million) in revenues, up from C$310,907 in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.

Apr
11
Sponsored by
Personal Genome Diagnostics

This webinar will provide an overview of genomic alterations that play a role in immunotherapy response.

May
04
Sponsored by
Qiagen

This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants.